Today's Pre-Open Stock Movers:

XpresSpa Group, Inc. (Nasdaq: XSPA) 30% HIGHER; the company announced its XpresCheck subsidiary had entered into a national agreement with United Airlines to offer COVID-19 testing services starting with Newark Liberty International Airport (EWR) and Denver International Airport (DEN).

MacroGenics, Inc. (Nasdaq: MGNX) 19.3% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved MARGENZA, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease. MARGENZA is the first product approved from MacroGenics promising pipeline. The approval was based on safety and efficacy results from the pivotal Phase 3 SOPHIA trial.

Rite Aid (NYSE: RAD) 16.7% HIGHER; reported Q3 EPS of $0.40, $0.45 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $6.11 billion versus the consensus estimate of $5.84 billion.

Arbutus Biopharma (NASDAQ: ABUS) 15.9% HIGHER; H.C. Wainwright initiates coverage on with a Buy rating and a price target of $10.00.

Selecta Biosciences (NASDAQ: SELB) 9.6% HIGHER; Chief Medical Officer, Peter Traber, bought 40,000 shares on 12/14 at $3.24.

Qutoutiao (NASDAQ: QTT) 8% LOWER; reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $166.4 million versus the consensus estimate of $174.9 million.

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) 7.7% LOWER; announced today the pricing of its underwritten public offering of 2,250,000 shares of its common stock at a price to the public of $42.00 per share.

Progenity (NASDAQ: PROG) 7.5% HIGHER; COO, Damon Silvestry, bought 63,870 shares on 12/15 at $4.07.

ADMA Biologics, Inc. (Nasdaq: ADMA) 6.3% HIGHER; announced that its Board of Directors has approved the adoption of a limited duration stockholder rights plan and declared a dividend distribution of one right for each outstanding share of common stock. The record date for such dividend distribution is December 30, 2020. The rights plan expires, without any further action being required to be taken by ADMAs Board of Directors, on December 15, 2021.

Roku, Inc. (NASDAQ: ROKU) 5.6% HIGHER; Roku and WarnerMedia today announced an agreement to bring HBO Max to the Roku platform. Starting tomorrow, Dec. 17, Roku users will be able to download HBO Max from the Roku channel store and subscribe directly on their Roku device to access all of HBO Max, which includes 10,000 hours of curated premium storytelling from the iconic brands of HBO, Warner Bros., DC, Adult Swim and much more. For users who have already subscribed to HBO through their Roku devices, the HBO app will automatically update to become the HBO Max app, and they will be able to log in using their existing HBO credentials.

ABM Industries (NYSE: ABM) 4.1% LOWER; reported Q4 EPS of $0.69, $0.01 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.43 billion. ABM Industries sees Q1 2021 EPS of $0.60-$0.65, versus the consensus of $0.47.

Lennar Corp. (NYSE: LEN) 3% HIGHER; reported Q4 EPS of $2.83, $0.46 better than the analyst estimate of $2.37. Revenue for the quarter came in at $6.83 billion versus the consensus estimate of $6.65 billion.

New Residential Investment (NYSE: NRZ) 2.8% HIGHER; declared a quarterly dividend of $0.20 per share, or $0.8 annualized. This is a 33.3% increase from the prior dividend of $0.15.

iQIYI, Inc. (Nasdaq: IQ) 2.7% LOWER; announced the pricing of its public offering of US$800 million in aggregate principal amount of 4.00% convertible senior notes due 2026 (the "Notes"), and the pricing of its public offering of an aggregate of 40,000,000 American Depositary Shares (the "ADSs") at a price to public of US$17.50 per ADS. Each ADS represents seven Class A ordinary shares of the Company. The Company has granted the underwriters in the Notes offering a 30-day option to purchase up to an additional US$100 million aggregate principal amount of the Notes, and it has granted the underwriters in the ADS offering a 30-day option to purchase up to 6,000,000 additional ADSs.

GSX Techedu Inc. (NYSE: GSX) 1.6% LOWER; downgraded to Neutral at UBS

ElectraMeccanica (NASDAQ: SOLO) 1.2% HIGHER; Stifel initiates coverage with a Buy rating and a price target of $9.00.